Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer

NCT02381912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2016-03-09

No results posted yet for this study

Summary

The purpose of the study is to investigate sexual function in patients suspected of non muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual function is underdiagnosed in patients with non-muscle invasive bladder cancer and that active examination and treatment may worsen the sexual function.

Conditions

  • Urinary Bladder Neoplasms
  • Sexual Dysfunction, Physiological
  • Sexual Dysfunctions, Psychological
  • Erectile Dysfunction
  • Hematuria

Interventions

OTHER

EORTC QLQ-C30 and EORTC BLS-24 questionnaire

Questionnaires answered at baseline and 4 months follow up.

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Peter B Østergren, MD · Herlev Hospital, Department of Urology

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381912 on ClinicalTrials.gov